{"organizations": [], "uuid": "e9c100d85f807893a36615ede011c35f6f39bb67", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 4, "shares": 4, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "jp.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XN922_3nKsJ_TOP_20180220034013.jpg", "site_section": "", "section_title": "", "url": "http://jp.wsj.com/articles/SB12326978829182843535204584056700317102132", "country": "US", "domain_rank": 387, "title": "バイオジェンCEO、株安は「過剰反応」 アルツハイマー薬治験 - WSJ", "performance_score": 0, "site": "wsj.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-20T12:13:00.000+02:00", "replies_count": 0, "uuid": "e9c100d85f807893a36615ede011c35f6f39bb67"}, "author": "Peter Landers", "url": "http://jp.wsj.com/articles/SB12326978829182843535204584056700317102132", "ord_in_thread": 0, "title": "バイオジェンCEO、株安は「過剰反応」 アルツハイマー薬治験 - WSJ", "locations": [], "entities": {"persons": [{"name": "dow jones", "sentiment": "none"}], "locations": [], "organizations": [{"name": "news corp", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. DOW JONES ", "external_links": [], "published": "2018-02-20T12:13:00.000+02:00", "crawled": "2018-02-23T11:02:52.021+02:00", "highlightTitle": ""}